68 related articles for article (PubMed ID: 10562759)
21. Cost-effectiveness of six strategies for Helicobacter pylori diagnosis and management in uninvestigated dyspepsia assuming a high resource intensity practice pattern.
Holmes KP; Fang JC; Jackson BR
BMC Health Serv Res; 2010 Dec; 10():344. PubMed ID: 21176158
[TBL] [Abstract][Full Text] [Related]
22. Proton pump inhibitor or testing for Helicobacter pylori as the first step for patients presenting with dyspepsia? A cluster-randomized trial.
Jarbol DE; Kragstrup J; Stovring H; Havelund T; Schaffalitzky de Muckadell OB
Am J Gastroenterol; 2006 Jun; 101(6):1200-8. PubMed ID: 16771937
[TBL] [Abstract][Full Text] [Related]
23. H. pylori testing and endoscopy for dyspepsia in primary care. Test and treat seems best.
Lancaster Smith MJ
BMJ; 2001 Aug; 323(7308):343. PubMed ID: 11548682
[No Abstract] [Full Text] [Related]
24. [Helicobacter pylori eradication treatment in non-ulcer dyspepsia].
Carmona-Sánchez R
Rev Gastroenterol Mex; 2004; 69(4):288-9. PubMed ID: 15765983
[No Abstract] [Full Text] [Related]
25. Key topics in Helicobacter pylori eradication in the management of the dyspeptic patient: a panel discussion.
Kearney DJ; Mégraud F
Eur J Gastroenterol Hepatol; 2001 Aug; 13 Suppl 2():S17-21. PubMed ID: 11686229
[TBL] [Abstract][Full Text] [Related]
26. Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia.
Koskenpato J; Farkkilä M; Sipponen P
Am J Gastroenterol; 2001 Oct; 96(10):2866-72. PubMed ID: 11693319
[TBL] [Abstract][Full Text] [Related]
27. Absence of symptomatic benefit of lansoprazole, clarithromycin, and amoxicillin triple therapy in eradication of Helicobacter pylori positive, functional (nonulcer) dyspepsia.
Veldhuyzen van Zanten S; Fedorak RN; Lambert J; Cohen L; Vanjaka A
Am J Gastroenterol; 2003 Sep; 98(9):1963-9. PubMed ID: 14499772
[TBL] [Abstract][Full Text] [Related]
28. Management strategies for duodenal ulcer in India in the helicobacter pylori era: an economic analysis.
Ghoshal UC; Das A
Natl Med J India; 2002; 15(3):140-4. PubMed ID: 12186326
[TBL] [Abstract][Full Text] [Related]
29. Impact of Helicobacter pylori on the management of dyspepsia in primary care.
Bennett K; Feely J; Thornton O; Dobson M; O'Morain CA; O'Connor HJ
Aliment Pharmacol Ther; 2006 Aug; 24(4):637-41. PubMed ID: 16907896
[TBL] [Abstract][Full Text] [Related]
30. Symptomatic treatment and H. pylori eradication therapy for nonulcer dyspepsia.
Smucny J
Am Fam Physician; 2001 Nov; 64(9):1605-8. PubMed ID: 11730316
[No Abstract] [Full Text] [Related]
31. Economic consequences of near-patient test results: the case of tests for the Helicobacter Pylori bacterium in dyspepsia.
Fauli S; Thue G
Eur J Health Econ; 2008 Aug; 9(3):221-8. PubMed ID: 17570004
[TBL] [Abstract][Full Text] [Related]
32. Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia.
Perri F; Andriulli A
N Engl J Med; 2000 Feb; 342(8):589-90. PubMed ID: 10691507
[No Abstract] [Full Text] [Related]
33. Helicobacter pylori and non-malignant diseases.
Rokkas T; Simsek I; Ladas S
Helicobacter; 2007 Oct; 12 Suppl 1():20-2. PubMed ID: 17727456
[TBL] [Abstract][Full Text] [Related]
34. Role of eradication of Cag A Helicobacter pylori in non ulcer dyspepsia.
Babu V; Kate V; Ananthakrishnan N
Trop Gastroenterol; 2005; 26(4):211-4. PubMed ID: 16737055
[TBL] [Abstract][Full Text] [Related]
35. Outcomes of initial noninvasive Helicobacter pylori testing in U.S. primary care patients with uninvestigated dyspepsia.
Ladabaum U; Fendrick AM; Scheiman JM
Am J Gastroenterol; 2001 Jul; 96(7):2051-7. PubMed ID: 11467631
[TBL] [Abstract][Full Text] [Related]
36. Reducing dyspepsia costs in the community.
Duggan A; Westbrook J
Gut; 2002 Oct; 51(4):613; author reply 613. PubMed ID: 12235096
[No Abstract] [Full Text] [Related]
37. Helicobacter pylori eradication.
Wilcock M
Br J Gen Pract; 1997 Aug; 47(421):529. PubMed ID: 9302806
[No Abstract] [Full Text] [Related]
38. ABC of the upper gastrointestinal tract: implications of dyspepsia for the NHS.
Logan R; Delaney B
BMJ; 2001 Sep; 323(7314):675-7. PubMed ID: 11566833
[No Abstract] [Full Text] [Related]
39. Role of N-acetyl-cisteine in the treatment of H. pylori.
Ianiro G; Cammarota G; Gasbarrini A; Gasbarrini G
Minerva Gastroenterol Dietol; 2014 Mar; 60(1):101. PubMed ID: 24632772
[No Abstract] [Full Text] [Related]
40. Costs in the evaluation of dyspepsia.
Gelfand DW; Maglinte DD
Gastrointest Endosc; 1992; 38(5):634. PubMed ID: 1397933
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
